Skip to main content
Equibles
ESSI logo

ESSI · Eco Science Solutions, Inc. · Metrics

Track ESSI — free

Use ESSI with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research ESSI.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$0.06 At close · Oct 20
Rebalance outlook locked
Going-concern doubt — flagged Sep 14, 2026

Substantial doubt about the company's ability to continue as a going concern.

“As described above and in Note 1 to the financial statements, substantial doubt exists regarding the Company's ability to continue as a going concern.”
View the 10-Q filed Sep 14, 2026
Market Cap
$1.57M
Shares
24.95M
Volume · Oct 20 713 Avg daily vol (3M) 748

ESSI metrics

44 of 122 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$0.06
Market cap
$1.57M

Price action

20 metrics
Price change (1W)
+0.0%
Price change (30D)
+0.0%
Price change (3M)
-42.3%
Price change (6M)
—
Price change (YTD)
—
Price change (1Y)
—
Trailing year
Price change (5Y)
—
52-week high
—
52-week low
—
Change from 52-week high
—
Change from 52-week low
—
Annualized volatility
—
Annualized volatility (3M)
—
Beta
—
RSI (14D)
47.5
Price vs SMA 50
—
Price vs SMA 200
—
Avg volume (3M)
748
Relative volume
1.0
Average dollar volume
$73

Company

3 metrics
Sector
Healthcare
Industry
Health Information Services
Shares outstanding
24.95M

Valuation

12 metrics
P / E (TTM)
0.0
Trailing earnings · reciprocal yield 7,301.6%
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
712.9×
reciprocal yield 0.1%
P / book
—
FCF yield
—
TTM · current market cap
Buyback yield
0.5%
P / FCF
—
P / operating cash flow
—
Earnings yield
603.0%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
0.5%
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
—

Profitability

9 metrics
Gross margin
—
Operating margin
-42,594.2%
Trailing 12 months
Net margin
429,904.4%
Gross profit (TTM)
$0
Operating profit (TTM)
−$939,202
Net income (TTM)
$9.48M
Trailing 12 months
Diluted EPS (TTM)
$4.60
FCF margin
—
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
$0.00
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
$-0.23
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
$4.35
Operating cash flow per diluted share (TTM)
$-0.09
Free cash flow per diluted share (TTM)
$-1.40
Capital expenditures per diluted share (TTM)
$0.01
R&D per diluted share (TTM)
$0.06
Stock compensation per diluted share (TTM)
—
Book value per share
$-0.04

Growth

11 metrics
Revenue growth YoY
—
Year over year
Net income growth YoY
—
Revenue (TTM)
$2,205
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+1,078.0%
Year over year · more shares
Revenue CAGR (3Y)
—
Revenue CAGR (5Y)
—
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
—
Return on assets
8,999.4%
Debt / equity
—
Current ratio
0.0
EBITDA (TTM)
—
Free cash flow (TTM)
—
Quick ratio
—
Interest coverage
-11.0
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$15,551
Total assets
$105,334
Total debt
—

Cash flow & spend

7 metrics
Operating cash flow (TTM)
−$222,447
Capital expenditures (TTM)
$13,266
R&D (TTM)
$269,835
SG&A (TTM)
—
Stock compensation (TTM)
—
R&D / revenue
12,237.4%
Stock compensation / revenue
—

Ownership (13F)

9 metrics
13F filers
—
13F filer change QoQ
—
Institutional ownership
—
Conviction holders (share of 13F filers)
—
Crowding (high-turnover and private-fund holders)
—
Private-fund adviser ownership
—
Active holders' share change QoQ
—
Holder tenure
—
Price vs estimated holder cost
—

Ownership (registered funds)

1 metrics
Index-fund ownership
0.0%

Short interest

3 metrics
Short interest
—
Latest settlement
Days to cover
—
Short-squeeze score
—

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
Flagged
Key facts CIK 1490873 CUSIP 27888G302 Visit website Investor relations